Toxicological Sciences 60, 373-378 (2001)
Copyright © 2001 by the Society of Toxicology
SAFETY EVALUATION |
Short-Term (13-week) Toxicity Study of 5-Bromo-6-methoxy-5,6- dihydro-3'-azidothymidine-5'-(p-bromophenyl) Methoxyalaninyl Phosphate (WHI-07), a Novel Anti-HIV and Contraceptive Agent, in B6C3F1 Mice
* Drug Discovery Program, Departments of Reproductive Biology and
Virology, Parker Hughes Institute, St. Paul, Minnesota 55113
The zidovudine derivative, WHI-07 (5-bromo-6-methoxy-5,6-dihydro-3'-azidothymidine-5'-(p-bromophenyl) methoxyalaninyl phosphate), is a dual-function spermicidal agent with potent anti-HIV activity. In this study, groups of 20 female B6C3F1 mice were exposed intravaginally to a gel microemulsion containing 0, 0.5, 1.0, or 2.0% WHI-07, 5 days per week for 13 consecutive weeks. On a molar basis, these concentrations of WHI-07 are 1400- to 5700-times higher than its spermicidal EC50 and 1.4 x 106 to 5.7 x 106 times higher than its in vitro anti-HIV IC50. After 13 weeks of intravaginal treatment, mice were evaluated for toxicity. The endpoints that were used for evaluation included survival, body weight, hematologic and clinical chemistry profiles, absolute and relative organ weights, and histopathology. No effects related to WHI-07 treatments were observed on survival, mean body weight, and mean body-weight gain. Repeated intravaginal exposure of mice to WHI-07 for 13 weeks had no toxicologically significant effect on organ weights, and did not cause any adverse changes in hematology parameters or blood chemistry profiles. Extensive histopathologic examination of tissues showed no lesions of pathologic significance. Thus, intravaginal application of WHI-07, for up to 13 weeks, does not cause systemic toxicity.
Key Words: 13-week intravaginal; zidovudine; HIV/AIDS; microbicide.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  O. J. D'Cruz and F. M. Uckun Preclinical Evaluation of a Dual-Acting Microbicidal Prodrug WHI-07 in Combination with Vanadocene Dithiocarbamate in the Female Reproductive Tract of Rabbit, Pig, and Cat Toxicol Pathol, December 1, 2007; 35(7): 910 - 927. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K V R Reddy, C Aranha, S M Gupta, and R D Yedery Evaluation of antimicrobial peptide nisin as a safe vaginal contraceptive agent in rabbits: in vitro and in vivo studies Reproduction, July 1, 2004; 128(1): 117 - 126. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. J. D'Cruz, B. Waurzyniak, and F. M. Uckun Antiretroviral Spermicide WHI-07 Prevents Vaginal and Rectal Transmission of Feline Immunodeficiency Virus in Domestic Cats Antimicrob. Agents Chemother., April 1, 2004; 48(4): 1082 - 1088. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. J. D'Cruz, B. Waurzyniak, and F. M. Uckun Mucosal Toxicity Studies of a Gel Formulation of Native Pokeweed Antiviral Protein Toxicol Pathol, February 1, 2004; 32(2): 212 - 221. [Abstract] [PDF]
|
|
|
|
|
|
O. J. D'Cruz, D. Erbeck, and F. M. Uckun Developmental Toxicology Studies of WHI-07, a Novel Nucleoside Analogue-Based Dual-Function Microbicide, Administered Intravaginally to Rabbits Toxicol Pathol, October 1, 2003; 31(6): 698 - 708. [Abstract] [PDF]
|
|
|
|
 |
|
 O. J. D'Cruz and F. M. Uckun Pre-clinical safety evaluation of novel nucleoside analogue-based dual-function microbicides (WHI-05 and WHI-07) J. Antimicrob. Chemother., December 1, 2002; 50(6): 793 - 803. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. J. D'Cruz, B. Waurzyniak, and F. M. Uckun A 13-Week Subchronic Intravaginal Toxicity Study of the Novel Broad-Spectrum Anti-HIV and Spermicidal Agent, N-[2-(1-cyclohexenyl)ethyl]-N'-[2-(5-bromopyridyl)]-thiourea (PHI-346) in Mice Toxicol Pathol, October 1, 2002; 30(6): 687 - 695. [Abstract] [PDF]
|
|